Comparison of Pediatric Forearm Fracture Fixation Between Single- and Double-Elastic Stable Intramedullary Nailing

Sheng-Hu Du1, Yong-Zeng Feng, Yi-Xing Huang

  • 1Department of Orthopaedic Surgery, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Insights

Single elastic stable intramedullary nailing (ESIN) for pediatric forearm fractures is as effective as double ESIN. This approach offers comparable outcomes with potentially lower costs and shorter surgery times.

Area of Science:

  • Orthopedics
  • Pediatric Surgery
  • Traumatology

Background:

  • Pediatric both-bone forearm fractures are common injuries.
  • Elastic stable intramedullary nailing (ESIN) is a widely used fixation method.
  • Comparing single- versus double-ESIN for these fractures requires further investigation.

Purpose of the Study:

  • To evaluate and compare the outcomes of single-elastic stable intramedullary nailing (S-ESIN) and double-elastic stable intramedullary nailing (D-ESIN) for pediatric both-bone forearm fractures.

Main Methods:

  • Retrospective analysis of 49 pediatric patients with both-bone forearm fractures treated with ESIN.
  • Comparison between S-ESIN (radius fixation only) and D-ESIN (radius and ulna fixation).
  • Evaluation of surgical duration, fluoroscopy time, hospitalization cost, cast duration, union time, radiographic outcomes, clinical results, and complications.

Main Results:

  • S-ESIN group showed significantly lower surgical duration, fluoroscopy times, and hospitalization costs.
  • The S-ESIN group had a longer period of cast removal but acceptable ulna angulation (<10 degrees).
  • The D-ESIN group had a higher incidence of delayed ulna union; however, no significant differences in forearm motion loss or complication rates were observed between groups.

Conclusions:

  • Single-ESIN fixation of the radius alone is an effective treatment for pediatric both-bone forearm fractures.
  • S-ESIN demonstrates comparable clinical and radiographic outcomes to D-ESIN.
  • S-ESIN is a viable and potentially preferred treatment option in the pediatric population.